Search
for
Sort by
Research
30-60 / 1000+ results
research A Proposal from Steven C. Chang, MD
The document's conclusion cannot be provided because the document is not readable.
research POSTTEST: EXPIRATION DATE: OCTOBER 2011
research Advertiser Beware
The document's conclusion cannot be provided because the document is not readable or understandable.
research Message from Paul J. McAndrews, Program Chair of the 2010 Annual Meeting
The document's content couldn't be processed to provide a conclusion.
research Message from Paul J. McAndrews, Program Chair of the 2010 Annual Meeting
The document's content couldn't be processed to provide a conclusion.
research Laser-Guided Hairline Design and Donor Strip Marking
The document's conclusion cannot be provided as the content is not available.
research 409 ANDROGEN RECEPTOR GENE POLYMORPHISM (SNP RS6152) – ITS RELATIONSHIP TO ANDROGEN-SENSITIVE GENES EXPRESSION IN BENIGN PROSTATIC HYPERPLASIA, CARCINOMA OF THE PROSTATE AND ANDROGENETIC ALOPECIA
Gene variation affects prostate issues and hair loss.
research Pioneer's Page
The document could not be read or understood.
research Abstracts of Communications
research Contents Vol. 240, 2024
research Frontal hairline design
The document's conclusion cannot be provided because the content is not accessible.
research 45th AOMSI Conference
I'm sorry, but I can't provide a summary as I don't have the specific details about the "45th AOMSI Conference".
research Contents list
research LB793 A phase 1, open-Label, single ascending dose study in healthy subjects of the safety, tolerability and pharmacokinetics of ASLAN004, a novel IgG anti-IL-13 receptor alpha 1 Inhibitor
ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.
research Live Workshop 1996
The document cannot be understood or processed.
research 396 A novel investigator global assessment score for the evaluation of keratosis pilaris
The document's conclusion cannot be provided because the content is not accessible.
research 709 Nitric oxide-releasing topical therapeutic agent for atopic dermatitis
SB414 may be an effective treatment for atopic dermatitis by reducing swelling and bacterial infection.
research 708 SIG-1451: A topical anti-inflammatory new chemical entity for atopic dermatitis (AD)
SIG-1451 could be a promising new treatment for atopic dermatitis.
research Heed Early Signs
Pay attention to early warnings.
research Meetings and Studies: Review of the Joint 3rd Asian & 5th Indian Associations of Hair Restoration Meeting—HAIRCON 2013
Unable to provide a summary as the document content is not provided.
research Mendeley Supplemental Document 1
research Co-Editors' Messages
The document's conclusion cannot be provided because the document cannot be parsed.
research Devices and genomic therapies
The document's conclusion cannot be provided because the document is not readable or understandable.
research Intermolecular NH 2 -/Carboxyl-terminal Interactions in Androgen Receptor Dimerization Revealed by Mutations That Cause Androgen Insensitivity
Mutations at Val-889 and Arg-752 disrupt key interactions in androgen receptor dimerization.
research A phase I study of MK-5108, an oral aurora A kinase inhibitor, in both monotherapy and in combination with docetaxel in patients with advanced solid tumors.
MK-5108 is safe and shows potential against tumors, especially alone.
research LB1048 Effectiveness of OR-101 in a murine model of atopic dermatitis
OR101 may effectively treat atopic dermatitis and similar skin conditions.
research Single‐center study to determine the safety and efficacy of CT‐707 in Chinese patients with advanced anaplastic lymphoma kinase‐rearranged non‐small‐cell lung cancer
CT-707 is effective and safe for treating certain Chinese lung cancer patients.